{"entity":{"type":"insider","cik":"0001639935","url":"/insider/0001639935","json_url":"/insider/0001639935.json","name":"Lydon Nicholas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":12,"first":"2017-01-31","last":"2020-10-05","span_basis":"filed_date"},"name_variants":[{"name":"Lydon Nicholas","source":"filing","n_filings":12,"first_seen":"2017-01-31","last_seen":"2020-10-05"}],"transactions":[{"id":2575469,"accession":"0001179110-20-010226","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-010226","line_url":"/filing/0001179110-20-010226","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001639935","owner_name":"Lydon Nicholas","owner_display_name":"Lydon Nicholas","owner_url":"/insider/0001639935","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9815.0,"shares_display":"9,815","price_per_share":93.08150993377484,"price_display":"93.08","price_state":"stated","total_value":913595.02,"total_display":"913,595.02","total_whole":"913,595","shares_owned_after":38814.0,"shares_owned_after_display":"38,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-05","scope":"insider","n_lines":3},{"id":2310872,"accession":"0001179110-20-009900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-009900","line_url":"/filing/0001179110-20-009900#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001639935","owner_name":"Lydon Nicholas","owner_display_name":"Lydon Nicholas","owner_url":"/insider/0001639935","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":40000.0,"total_display":"40,000.00","total_whole":"40,000","shares_owned_after":47240.0,"shares_owned_after_display":"47,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-17","filed_date":"2020-09-21","scope":"insider"},{"id":2355341,"accession":"0001179110-20-008109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-008109","line_url":"/filing/0001179110-20-008109","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001639935","owner_name":"Lydon Nicholas","owner_display_name":"Lydon Nicholas","owner_url":"/insider/0001639935","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26007.0,"shares_display":"26,007","price_per_share":80.45338101280424,"price_display":"80.45","price_state":"stated","total_value":2092351.08,"total_display":"2,092,351.08","total_whole":"2,092,351","shares_owned_after":48340.0,"shares_owned_after_display":"48,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-06","filed_date":"2020-07-08","scope":"insider","n_lines":2},{"id":2922146,"accession":"0001104659-20-081384","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-081384","line_url":"/filing/0001104659-20-081384#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001639935","owner_name":"Lydon Nicholas","owner_display_name":"Lydon Nicholas","owner_url":"/insider/0001639935","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2825.0,"shares_display":"2,825","price_per_share":80.13,"price_display":"80.13","price_state":"stated","total_value":226367.25,"total_display":"226,367.25","total_whole":"226,367","shares_owned_after":73747.0,"shares_owned_after_display":"73,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-02","filed_date":"2020-07-06","scope":"insider"},{"id":2922143,"accession":"0001104659-20-081384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-081384","line_url":"/filing/0001104659-20-081384#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001639935","owner_name":"Lydon Nicholas","owner_display_name":"Lydon Nicholas","owner_url":"/insider/0001639935","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":80.21,"price_display":"80.21","price_state":"stated","total_value":104273.0,"total_display":"104,273.00","total_whole":"104,273","shares_owned_after":76572.0,"shares_owned_after_display":"76,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-06","scope":"insider"},{"id":2707788,"accession":"0001179110-20-007760","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-007760","line_url":"/filing/0001179110-20-007760#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001639935","owner_name":"Lydon Nicholas","owner_display_name":"Lydon Nicholas","owner_url":"/insider/0001639935","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":32000.0,"total_display":"32,000.00","total_whole":"32,000","shares_owned_after":75622.0,"shares_owned_after_display":"75,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-25","scope":"insider"},{"id":2973547,"accession":"0001179110-20-007717","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-007717","line_url":"/filing/0001179110-20-007717#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001639935","owner_name":"Lydon Nicholas","owner_display_name":"Lydon Nicholas","owner_url":"/insider/0001639935","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13017.0,"shares_display":"13,017","price_per_share":80.29,"price_display":"80.29","price_state":"stated","total_value":1045134.93,"total_display":"1,045,134.93","total_whole":"1,045,135","shares_owned_after":76022.0,"shares_owned_after_display":"76,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-23","scope":"insider"},{"id":8022314,"accession":"0001179110-19-007778","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-19-007778","line_url":"/filing/0001179110-19-007778#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001639935","owner_name":"Lydon Nicholas","owner_display_name":"Lydon Nicholas","owner_url":"/insider/0001639935","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":90.36,"price_display":"90.36","price_state":"stated","total_value":2259000.0,"total_display":"2,259,000.00","total_whole":"2,259,000","shares_owned_after":127727.0,"shares_owned_after_display":"127,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-13","filed_date":"2019-06-17","scope":"insider"},{"id":8061645,"accession":"0001179110-19-007732","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-19-007732","line_url":"/filing/0001179110-19-007732","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001639935","owner_name":"Lydon Nicholas","owner_display_name":"Lydon Nicholas","owner_url":"/insider/0001639935","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":84.76648,"price_display":"84.77","price_state":"stated","total_value":2119162.0,"total_display":"2,119,162.00","total_whole":"2,119,162","shares_owned_after":166527.0,"shares_owned_after_display":"166,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-12","filed_date":"2019-06-14","scope":"insider","n_lines":5},{"id":6133655,"accession":"0001209191-18-025382","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-18-025382","line_url":"/filing/0001209191-18-025382","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001639935","owner_name":"Lydon Nicholas","owner_display_name":"Lydon Nicholas","owner_url":"/insider/0001639935","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33000.0,"shares_display":"33,000","price_per_share":86.87614107272728,"price_display":"86.88","price_state":"stated","total_value":2866912.6554,"total_display":"2,866,912.66","total_whole":"2,866,913","shares_owned_after":291196.0,"shares_owned_after_display":"291,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-16","filed_date":"2018-04-18","scope":"insider","n_lines":7},{"id":5954935,"accession":"0001179110-18-003315","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-18-003315","line_url":"/filing/0001179110-18-003315","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001639935","owner_name":"Lydon Nicholas","owner_display_name":"Lydon Nicholas","owner_url":"/insider/0001639935","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":87.8942428,"price_display":"87.89","price_state":"stated","total_value":2197356.07,"total_display":"2,197,356.07","total_whole":"2,197,356","shares_owned_after":193131.0,"shares_owned_after_display":"193,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-28","filed_date":"2018-03-02","scope":"insider","n_lines":4},{"id":4072452,"accession":"0001179110-17-004740","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-004740","line_url":"/filing/0001179110-17-004740","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001639935","owner_name":"Lydon Nicholas","owner_display_name":"Lydon Nicholas","owner_url":"/insider/0001639935","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":40.0532,"price_display":"40.05","price_state":"stated","total_value":2803724.0,"total_display":"2,803,724.00","total_whole":"2,803,724","shares_owned_after":204127.0,"shares_owned_after_display":"204,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-14","filed_date":"2017-03-16","scope":"insider","n_lines":2},{"id":4538904,"accession":"0001209191-17-006404","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-006404","line_url":"/filing/0001209191-17-006404#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001639935","owner_name":"Lydon Nicholas","owner_display_name":"Lydon Nicholas","owner_url":"/insider/0001639935","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16666.0,"shares_display":"16,666","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":249990.0,"total_display":"249,990.00","total_whole":"249,990","shares_owned_after":287623.0,"shares_owned_after_display":"287,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-31","filed_date":"2017-01-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001597264","name":"Blueprint Medicines Corp","url":"/issuer/0001597264","role":"Director","n_filings":10,"first_seen":"2017-03-16","last_seen":"2020-10-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001370053","name":"ANAPTYSBIO INC","url":"/issuer/0001370053","role":"Director","n_filings":2,"first_seen":"2017-01-31","last_seen":"2018-04-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001639935","retrieved_at":"2026-08-25T02:50:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}